Clinical effect of Quantianma capsules combined with flupentixol and melitracen tablets on chronic migraine
10.3969/j.issn.1005-1678.2017.10.042
- VernacularTitle:全天麻胶囊联合氟哌噻吨美利曲辛片治疗慢性偏头痛的临床效果观察
- Author:
yan Hong ZHANG
;
wei Jian JIANG
;
yu Xin WANG
- Keywords:
Quantianma capsules;
flupentixol and melitracen tablets;
chronic migraine
- From:
Chinese Journal of Biochemical Pharmaceutics
2017;37(10):104-106
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyse the clinical effect of Quantianma capsules combined with flupentixol and melitracen tablets on chronic migraine. Methods 130 patients with chronic migraine were treated with flupentixol and melitracen tablets, were divided into control group and observation group, 65 patients in each group. The observation group were given to Quantianma capsules. Results The effective rate of observation group with 90.77% was higher than control group with 73.85%(P<0.05). After treatment, the number of migraine attacks, duration time, VAS score, HAMA and HAMD score and mean flow velocity of cerebral artery of two groups were lower than pre-treatment and observation group were lower than that of control group(P<0.05). Adverse reactions were similar in the two groups. Conclusion Quantianma capsules can improve the efficacy of treatment of chronic migraine combined with flupentixol and melitracen tablets and improve condition with few adverse effects.
